People · Operator
Named in public records as an officer, director or promoter · active 2021–2023 · Biotechnology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Window Therapeutics, Inc. | — | Biotechnology | Series A | $7.5M | $57.3M | 2023 |
| Ikaika Therapeutics, Inc. | — | Pharma | Pre-Seed | $1.0M | $22.5M | 2021 |
Chih-Kao Hu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chih-Kao Hu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kenneth Anderson | 1 | 5 |
| James Lu | 1 | 3 |
| LUSONG LUO | 1 | 3 |
| Jeremiah Johnson | 1 | 1 |
| ELIZABETH MCNALLY | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.